June 11, 2026— Penumbra, Inc. has received U.S. Food and Drug Administration (FDA) clearance for Thunderbolt, expanding its computer assisted vacuum thrombectomy (CAVT) technology to address acute ...
Interventional Cardiology
-
-
May 11, 2026 — In May, Robocath announced the completion of patient enrollment in the FIH (First-In-Human) clinical study evaluating its next-generation robotic system for percutaneous coronary ...
July 9, 2026 — On July 9, Stereotaxis announced that it has completed its previously announced acquisition of Robocath ...
July 10, 2026
June 17, 2026 — VahatiCor, Inc., a medtech company developing interventional therapies for coronary microvascular ...
June 22, 2026
June 15, 2006 — Penumbra, Inc. has secured the CE Mark in Europe for Thunderbolt, further laying the groundwork for ...
June 15, 2026Sponsored Content
Feature | Thrombectomy Devices
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
June 01, 2026
June 11, 2026— Penumbra, Inc. has received U.S. Food and Drug Administration (FDA) clearance for Thunderbolt, expanding ...
June 12, 2026
May 11, 2026 — In May, Robocath announced the completion of patient enrollment in the FIH (First-In-Human) clinical ...
June 04, 2026
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
June 01, 2026Sponsored Content
Feature | Cardiac Imaging
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
March 13, 2026
May 13, 2026 — According to a recently released report, the global cath lab services market was valued at $46.0 billion ...
May 13, 2026
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
March 13, 2026